|
1
|
Jones SB: Cancer in the developing world:
A call to action. BMJ. 319:505–508. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walsh SR, Cook EJ, Goulder F, Justin TA
and Keeling NJ: Neutrophil-lymphocyte ratio as a prognostic factor
in colorectal cancer. J Surg Oncol. 91:181–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim JH, Lee JY, Kim HK, Lee JW, Jung SG,
Jung K, Kim SE, Moon W, Park MI and Park SJ: Prognostic
significance of the neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in patients with stage III and IV
colorectal cancer. World J Gastroenterol. 23:505–515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Halazun KJ, Hardy MA, Rana AA, Woodland DC
IV, Luyten EJ, Mahadev S, Witkowski P, Siegel AB, Brown RS Jr and
Emond JC: Negative impact of neutrophil-lymphocyte ratio on outcome
after liver transplantation for hepatocellular carcinoma. Ann Surg.
250:141–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhatti I, Peacock O, Lloyd G, Larvin M and
Hall RI: Preoperative hematologic markers as independent predictors
of prognosis in resected pancreatic ductal adenocarcinoma:
Neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg.
200:197–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sarraf KM, Belcher E, Raevsky E, Nicholson
AG, Goldstraw P and Lim E: Neutrophil/lymphocyte ratio and its
association with survival after complete resection in non-small
cell lung cancer. J Thorac Cardiovasc Surg. 137:425–428. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizunuma M, Yokoyama Y, Futagami M, Aoki
M, Takai Y and Mizunuma H: The pretreatment
neutrophil-to-lymphocyte ratio predicts therapeutic response to
radiation therapy and concurrent chemoradiation therapy in uterine
cervical cancer. Int J Clin Oncol. 20:989–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan D, Fu Y, Su Q and Wang H: Prognostic
role of platelet-lymphocyte ratio in colorectal cancer: A
systematic review and meta-analysis. Medicine (Baltimore).
95:e38372016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miao Y, Yan Q, Li S, Li B and Feng Y:
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are
predictive of chemotherapeutic response and prognosis in epithelial
ovarian cancer patients treated with platinum-based chemotherapy.
Cancer Biomark. 17:33–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Xu F, Pan J, Zhu Y, Shao X, Sha J,
Wang Z, Cai Y, Liu Q, Dong B, et al: Platelet to lymphocyte ratio
as an independent prognostic indicator for prostate cancer patients
receiving androgen deprivation therapy. BMC Cancer. 16:3292016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen S, Guo J, Feng C, Ke Z, Chen L and
Pan Y: The preoperative platelet-lymphocyte ratio versus
neutrophil-lymphocyte ratio: Which is better as a prognostic factor
in oral squamous cell carcinoma? Ther Adv Med Oncol. 8:160–167.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH: WHO classification of tumours of female reproductive
organs. 4th edition. Lyon; IARC Press; 2014
|
|
13
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ardi VC, Kupriyanova TA, Deryugina EI and
Quigley JP: Human neutrophils uniquely release TIMP-free MMP-9 to
provide a potent catalytic stimulator of angiogenesis. Proc Natl
Acad Sci USA. 104:20262–20267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valle-Mendiola A, Gutiérrez-Hoya A,
Lagunas-Cruz Mdel C, Weiss-Steider B and Soto-Cruz I: Pleiotropic
Effects of IL-2 on Cancer: Its role in cervical cancer. Mediators
Inflamm. 2016:28495232016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakamura K, Nishida T, Haruma T, Haraga J,
Omichi C, Ogawa C, Kusumoto T, Seki N, Masuyama H and Hiramatsu Y:
Pretreatment platelet-lymphocyte ratio is an independent predictor
of cervical cancer recurrence following concurrent chemoradiation
therapy. Mol Clin Oncol. 3:1001–1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sabrkhany S, Griffioen AW and Oude Egbrink
MG: The role of blood platelets in tumor angiogenesis. Biochim
Biophys Acta. 1815:189–196. 2011.PubMed/NCBI
|
|
19
|
Huang EY, Hsu HC, Sun LM, Chanchien CC,
Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, et al:
Prognostic value of pretreatment carcinoembryonic antigen after
definitive radiotherapy with or without concurrent chemotherapy for
squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol
Biol Phys. 81:1105–1113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Cui T, Du L, Xu X, Tian B, Sun T,
Han C, Zhao X and Jing J: The correlation between the serum
squamous carcinoma antigen and the prognosis of recurrent cervical
squamous carcinoma. J Clin Lab Anal. 31:2017. View Article : Google Scholar
|
